23 May 2013
Keywords: novavax, vlp, flu, vaccine, enters, ph, ii
Article | 29 September 2008
USA-based Novavax has started inoculating healthy volunteers in a Phase II clinical trial of its virus-like particle-based seasonal influenza
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2008
22 May 2013
© 2013 thepharmaletter.com